Skip to main content

Syndros News

FDA Medwatch Alert: The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules USP 2.5 mg and Ziprasidone Hydrochloride Capsules 20 mg Due to Label Mix-Up

June 13, 2023 – La Vergne, TN, The Harvard Drug Group, LLC d/b/a Major Pharmaceutical and Rugby Laboratories is initiating a voluntary recall of a single lot of Dronabinol Capsules, USP, 2.5 mg and Z...

Insys Therapeutics Announces FDA Approval of Syndros (dronabinol) Oral Solution

PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) – Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys’ dronab...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Nausea / Vomiting - Chemotherapy Induced

Syndros patient information at Drugs.com